01633nam a2200337Ia 4500001001200000003000800012005001700020006001900037007001500056008004100071020001500112020001800127040002100145035002100166050002500187090001800212110013100230245032200361260005600683300001400739504004100753533015200794650004500946650003000991650003401021650003501055655003401090710002201124856013101146999001801277ebr10237094CaPaEBR20260707180647.0m        u        cr cn|||||||||080521s2008    dcu     sb    000 0 eng d  z0309118662  z9780309118668  aCaPaEBRcCaPaEBR  a(OCoLC)64675597614aRA644.I6bI56 2008eb  c111702d884162 aInstitute of Medicine (U.S.).bCommittee on Implemention of Antiviral Medication Strategies for an Influenza Pandemic.915764910aAntivirals for pandemic influenzah[electronic resource] :bguidance on developing a distribution and dispensing program /cCommittee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.  aWashington, DC :bNational Academies Press,cc2008.  ax, 122 p.  aIncludes bibliographical references.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2009.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aAntiviral agentsxEffectiveness.9157650 0aAntiviral agents.9157651 0aEpidemicsxPrevention.995307 0aInfluenzaxPrevention.9141580 7aElectronic books.2local91902 aebrary, Inc.919140uhttp://site.ebrary.com/lib/strathmore/Doc?id=10237094zAn electronic book accessible through the World Wide Web; click to view  c111702d88416